Dhanuka Agritech Q1 FY27 Call Transcript Released
Dhanuka Agritech released its Q1 FY27 earnings call transcript. Revenue declined 12.56% to ₹461.93 crore due to delayed monsoons. The company plans a new ₹200 crore formulation plant in Nagpur by April 2028 and will launch five new products soon. A 100% final dividend was considered.
The announcement details a decline in quarterly revenue, which is a material financial event. However, the company's long-term strategic plans (new plant, product launches) and the release of the call transcript provide context and forward-looking information, balancing the negative short-term results.
The company reported a decline in revenue for the quarter due to challenging industry conditions. While there are forward-looking plans like a new plant and product launches, the immediate financial performance was subdued, leading to a neutral sentiment.
Dhanuka Agritech Limited has released the transcript of its conference call held on August 3, 2026, with analysts and investors. The call, hosted by Antique Stock Broking Limited, discussed the company's un-audited financial results for the quarter ended June 30, 2026.
During the call, management acknowledged a challenging first quarter for the agrochemical industry due to delayed monsoons, impacting sowing activities and product demand. Revenue from operations for Q1 FY27 stood at ₹461.93 crore, a decrease of 12.56% from ₹528.29 crore in Q1 FY26. EBITDA was ₹55.01 crore, and profit after tax was ₹36.30 crore. The company highlighted its strong balance sheet and cash generation despite these headwinds.
Key developments discussed included the final dividend of 100% (₹2 per equity share) considered at the 41st AGM and a previously completed buyback of 5 lakh shares at ₹1,400 per share, totaling ₹70 crore. The company also announced plans to set up a new manufacturing plant in Nagpur, Maharashtra, with an estimated outlay of up to ₹200 crore and a proposed capacity of 23,000 metric tons per annum, expected to be operational by April 2028. Additionally, Dhanuka Agritech plans to launch five new products in the upcoming months, including one liquid fertilizer, three fungicides, and one herbicide.
The management also addressed questions regarding international business expansion with acquired products from Bayer, the performance of new product launches, and the company's strategy for product introductions. Updates were provided on a GST notice, the potential for further international deals, and the nature of the Nagpur plant as a formulation unit. Guidance for FY27 was revised downwards due to monsoon uncertainties, with expectations of stronger momentum in Q2 and Q3. The company also discussed the CAPEX plan for the Nagpur facility, estimated at around ₹100 crore plus for FY27-28, and provided updates on the Dahej plant's revenue and EBITDA.
What to do with a filing like this
Dhanuka Agritech Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dhanuka Agritech Limited. Read the original for the full detail.